Telithromycin (Ketek™): General Safety Profile

Anti-Infective Drugs Advisory Committee

April 26, 2001

David Ross, M.D., Ph.D.

Division of Anti-Infective Drug Products

Center for Drug Evaluation and Research

U.S. Food and Drug Administration

Next slide

Back to first slide

View graphic version